Got Monkeypox? Probably Not.
So what's all the hoopla about?
If you’re not up to speed, here’s a glimpse of the mainstream take à la statnews.com
Monkeypox, a disease that rarely shows up outside a belt of countries across Central and West Africa, has exploded into the news recently, with cases reported in the United Kingdom, Spain, Portugal, the United States, Sweden, Italy, and likely Canada.
At this point, the cases are mainly being detected by clinics that treat sexually transmitted diseases and are being seen in men who have sex with men. But the World Health Organization and the Centers for Disease Control and Prevention have cautioned that to assume the virus is only circulating in a single subset of the population risks missing cases that may be occurring among other people.
Monkeypox causes a flu-like array of symptoms, but also comes with a distinctive rash; one telltale sign is the fact that lesions often appear on the palms of hands. So far it seems that the cases are being caused by viruses from the West African clade, which triggers milder disease than the other family of viruses, called the Congo Basin clade. All monkeypox viruses are cousins of the one that caused smallpox, the only human virus to have been eradicated.
Monkeypox is a viral zoonotic disease. Health authorities seem to agree that it’s rare and doesn’t seem to spread particularly easily between people. Human-to-human transmission has only been documented on rare occasion between very close contacts.
But that didn’t stopped the U.S. government from rushing to stockpile new vaccines.
According to a press release from European pharma company Bavarian Nordic, the United States exercised a $119 million option on the doses. The vaccines were purchased through the The Biomedical Advanced Research and Development Authority (BARDA). The U.S. government has an additional $180 million in options if it so chooses to exercise them.
And John’s Hopkins Center for Health Security wasted no time in publishing a fact sheet on it’s website yesterday.
Reactions in the Twitterverse run the gamut…
But it’s this timeline from Corey’s Digs that piqued my interest.
The timeline starts in 2001, but starts to get interesting in 2014, when Bill Gates and Wellcome Trust join forces to pursue “future smallpox treatment.”
And it should surprise no one that he recently warned of a smallpox terror attack (remember monkeypox and smallpox are related and are supposedly covered under the same vaccine)
And, of course, this is all coming just as the WHO is pushing for ultimate control over global public health decisions.
I do not claim to know what’s happening. But I do dabble in screenwriting and how can a screenwriter resist such a perfect collection of dots to connect?
Here’s how I might see this movie evolving…
There’s an explosion of immune dysregulation, autoimmunity and immune suppression following the the mass spike shot campaign that appears to get worse with each jab. Aggressive cancers, cardiac episodes, neurological diseases, POTS, and shingles are all on the rise. Flare-ups of old illnesses return and we see a resurgence of viral diseases that had previously been managed. Regulatory authorities panic and need a scapegoat for the increasingly obvious maladies that are becoming too widespread to suppress. One senior scientist (let’s call him Antonio Fraudchi) suggests we create a panic around a scary, poorly understood viral disease from Africa that has similar symptom profile to some of the things that are circulating. This way, the new explosion of illness can be attributed to the next public health crisis rather than being blamed on the failed policies and campaigns he devised and executed. It would also allow him to roll out the next wave of lucrative public health solutions that would line his pockets and keep the people under this spell, at least until the WHO sealed the deal and took things to the next level.
But I digress. This is real life. So I guess I’ll have to wait and see…